Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of E2022 donepezil transdermal tape: application sites and intervals
jRCT2080222090Phase 1
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCT2080222090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222090.